Nippon India Nifty Smallcap 250 Index Fund
Emcure Pharmaceuticals L · NSE
64,706 sh · ₹12.57 Cr
Nippon India Multi Cap Fund
0.6% of their portfolio
₹300.63 Cr
15,47,263 sh
Aditya Birla Sun Life ELSS Tax Saver Fund
1.7% of their portfolio
₹247.85 Cr
13,49,941 sh
SBI Flexicap Fund
90.0% of their portfolio
₹209.46 Cr
11,28,993 sh
Nippon India Pharma Fund
1.4% of their portfolio
₹124.53 Cr
6,40,910 sh
Nippon India ELSS Tax Saver Fund
0.7% of their portfolio
₹103.79 Cr
6,11,992 sh
Aditya Birla Sun Life Multi-Cap Fund
1.1% of their portfolio
₹80.74 Cr
4,39,742 sh
Aditya Birla Sun Life Small Cap Fund
1.2% of their portfolio
₹66.36 Cr
3,61,420 sh
Aditya Birla Sun Life Large & Mid Cap Fund
0.9% of their portfolio
₹50.59 Cr
2,75,555 sh
Vineeta Adityakumar Ruia
Investor
₹47.50 Cr
2,61,420 sh
Aditya Birla Sun Life Quant Fund
Fund
₹47.50 Cr
2,61,420 sh
Aditya Birla Sun Life Pharma & Healthcare Fund
3.2% of their portfolio
₹32.64 Cr
1,77,757 sh
HDFC Standard Life Insurnace
Investor
₹28.70 Cr
1,57,949 sh
FIIs raised their stake +1.5pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Nifty Smallcap 250 Index Fund
Emcure Pharmaceuticals L · NSE
64,706 sh · ₹12.57 Cr
Nippon India Multi Cap Fund
Emcure Pharmaceuticals L · NSE
15,47,263 sh · ₹300.63 Cr
ICICI Prudential Nifty Smallcap 250 ETF
Emcure Pharmaceuticals L · NSE
176 sh · ₹3.42 L
ICICI Prudential Nifty Smallcap 250 Index Fund
Emcure Pharmaceuticals L · NSE
14,738 sh · ₹2.86 Cr
Groww Mutual Fund (scheme IB18)
Emcure Pharmaceuticals L · NSE
740 sh · ₹14.38 L
Nippon India Nifty 500 Equal Weight Index Fund
Emcure Pharmaceuticals L · NSE
4,726 sh · ₹91.83 L
Groww Mutual Fund (scheme IB52)
Emcure Pharmaceuticals L · NSE
317 sh · ₹6.16 L
ICICI Prudential Nifty 500 Index Fund
Emcure Pharmaceuticals L · NSE
221 sh · ₹4.29 L
Groww Mutual Fund (scheme IB20)
Emcure Pharmaceuticals L · NSE
2,540 sh · ₹49.35 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
53 announcements on record for this company.
Promoter holding by quarter: Jun 2025 77.9%, Sep 2025 77.9%, Dec 2025 77.9%, Mar 2026 77.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 2.9%, Sep 2025 3.3%, Dec 2025 3.6%, Mar 2026 3.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 2.8%, Sep 2025 4.4%, Dec 2025 6.1%, Mar 2026 6.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.1pp
MF holding by quarter: Jun 2025 2.3%, Sep 2025 3.6%, Dec 2025 4.8%, Mar 2026 4.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
ICICI Prudential BSE 500 ETF
Emcure Pharmaceuticals L · NSE
767 sh · ₹14.90 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 77.9%, Sep 2025 77.9%, Dec 2025 77.9%, Mar 2026 77.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 2.9%, Sep 2025 3.3%, Dec 2025 3.6%, Mar 2026 3.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 2.8%, Sep 2025 4.4%, Dec 2025 6.1%, Mar 2026 6.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.1pp
MF holding by quarter: Jun 2025 2.3%, Sep 2025 3.6%, Dec 2025 4.8%, Mar 2026 4.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
53 announcements on record for this company.